Identification of patients receiving amyloid‐targeting therapies in observational studies using amyloid PET trajectories: Insights from LEADS

Abstract INTRODUCTION As amyloid‐targeting therapies (ATTs) enter clinical care, observational cohorts must accurately ascertain ATT exposure. We developed an approach to flag mis/undocumented ATT in the Longitudinal Early‐Onset Alzheimer's Disease Study using longitudinal amyloid positron emission...

Descripció completa

Dades bibliogràfiques

Autors principals:	Renaud La Joie, Ganna Blazhenets, Piyush Maiti, Konstantinos Chiotis, Ani Eloyan, Kala Kirby, Dustin Hammers, Robert A. Koeppe, Sarah F. Ackley, Justin Robison, David N. Soleimani‐Meigooni, Maria C. Carrillo, Bradford C. Dickerson, Liana G. Apostolova, Gil D. Rabinovici, for the LEADS consortium
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2026-04-01
Col·lecció:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Matèries:	Centiloids early‐onset Alzheimer's disease measurement error treatment‐related amyloid clearance
Accés en línia:	https://doi.org/10.1002/dad2.70408
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!